New horizons in cancer treatment

 The United States has approved the new treatment system called CERT (Cummeric Antigen Receiver Therapy) in the treatment of cancer. This procedure will prevent the prevention of patient's cancer by reproduction of the immune system.Referring to the decision as "historic", the US Food and Drug Administration said that the procedure "entered the new phase" of cancer treatment.UK doctors say that the decision was made to promote cancer treatment in a 'sensational stage'.This treatment system is known as 'living medicine' therapy. Through this therapies, 83 percent of all types of blad cancer patients get complete cure.It is not a common treatment method of cancer, such as surgery or chemotherapy. This 'living medicine' is created separately for each patient. These living drugs or CARs are made by collecting patient's white blood cells.The genetic mutation of white blood cells collected from the patient is re-inserted into the patient's body so that it can attack the cancer. When this 'cancer killer' finds his victim (cancer cell), he attacks him and continues to spread his cancer.Scott Gottlieb of the US Department of Food and Drug Administration said, "With the ability to reproduce the patient's own cells in the prevention of dangerous cancer, we are entering new horizons in innovative treatment."In the Philadelphia Children's Hospital, cancer treatment system was first used by the physician Stefan Group. He said the new initiative is 'very excited'. We have never seen such effective methods of cancer. "The patient who first used the CAR-T method, went to the point of death. He is currently cancer-free for five years. So far this therapy has been given to 63 patients. 83 percent of these patients were fully cured within three months of therapy. Information about its effect in the long term is still being collected.Although this therapy is not completely risk-free. Carr-T cells spread rapidly to the patient's body. This is because of the deadly 'sitokin release syndrome'. However, it can be controlled through medicines.Initially, CATT technology unveiled new possibilities for the treatment of cancer of one type, but doctors expressed hope that this technology will soon open the door to find ways to cure various types of cancer.David Maloney, director of Fred Hutchinson Cancer Research Center's cellular immunotherapy theme, said the decision of the Food and Drug Administration was "breakthrough". He said, "I believe this technology will soon open many new types of immunotherapy-based treatment in the treatment of various types of cancer."CART technology is considered to be effective for the treatment of various types of blood-related cancer. This treatment is not yet effective in the treatment of other cancers. "I'm sure this technology will improve further in the near future," said Satani, a pediatric atomologist at Columbia Medical University.